Reshma Kewalramani Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Reshma Kewalramani.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Reshma Kewalramani for May 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 288.37 | 9 | 2,595 | 26,626 | 26.6 K to 26.6 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 287.63 | 19 | 5,465 | 26,635 | 26.7 K to 26.6 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 286.07 | 27 | 7,724 | 26,654 | 26.7 K to 26.7 K (-0.10 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 283.76 | 10 | 2,838 | 26,681 | 26.7 K to 26.7 K (-0.04 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 282.74 | 4 | 1,131 | 26,691 | 26.7 K to 26.7 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 281.74 | 6 | 1,690 | 26,695 | 26.7 K to 26.7 K (-0.02 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 280.47 | 9 | 2,524 | 26,701 | 26.7 K to 26.7 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 279.70 | 7 | 1,958 | 26,710 | 26.7 K to 26.7 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 276.40 | 6 | 1,658 | 26,717 | 26.7 K to 26.7 K (-0.02 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 274.37 | 2 | 549 | 26,723 | 26.7 K to 26.7 K (-0.01 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Option Exercise | M | 155.57 | 510 | 79,341 | 3,567 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Option Exercise | M | 187.53 | 1,564 | 293,297 | 17,206 | |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 275.17 | 134 | 36,873 | 26,626 | 26.8 K to 26.6 K (-0.50 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 274.04 | 864 | 236,771 | 26,760 | 27.6 K to 26.8 K (-3.13 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 272.77 | 360 | 98,197 | 27,624 | 28 K to 27.6 K (-1.29 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 271.92 | 300 | 81,576 | 27,984 | 28.3 K to 28 K (-1.06 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 270.35 | 416 | 112,466 | 28,284 | 28.7 K to 28.3 K (-1.45 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Buy | M | 155.57 | 510 | 79,341 | 28,700 | 28.2 K to 28.7 K (+1.81 %) |
May 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Buy | M | 187.53 | 1,564 | 293,297 | 28,190 | 26.6 K to 28.2 K (+5.87 %) |